Skip to main content
SpringerLink
Log in

Drug company payments to doctors influence prescribing

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rhee TG, et al. Association Between Industry Payments to Physicians and Gabapentinoid Prescribing. JAMA Internal Medicine : 8 Jul 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2019.1082

  2. Khan R, et al. Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians. JAMA Internal Medicine : 8 Jul 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2019.0999

  3. Steinbrook R. Industry Payments and Physician Prescribing. JAMA Internal Medicine : 8 Jul 2019. Available from: URL: http://doi.org/10.1001/jamainternmed.2019.1081

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug company payments to doctors influence prescribing. PharmacoEcon Outcomes News 833, 17 (2019). https://doi.org/10.1007/s40274-019-6081-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6081-5

Search

Navigation